Navigation Links
Margaret Laub Appointed to IntelliDOT Board of Directors
Date:2/16/2009

- Two current members step down to become observers -

SAN DIEGO, Feb. 16 /PRNewswire/ -- IntelliDOT Corporation, a leading provider of wireless, handheld barcode point-of-care (BPOC) solutions to hospitals, today announced that Ms. Margaret Laub, Chief Executive Officer of Policy Studies Inc., Denver, Colo. has joined the IntelliDOT Board of Directors.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090121/LA60632LOGO)

"Margaret has a strong healthcare background that included a senior operating role at McKesson and she is currently the CEO of a healthcare IT business process outsourcing company," said Thomas G. Klopack, President and CEO of IntelliDOT Corporation. "She is an excellent, experienced operational addition to our board."

In addition to her role as CEO, Margaret Laub is a member of the Board of Directors of Policy Studies Inc. She leads the firm's efforts in providing US$180 million in private equity-backed consulting and business process outsourcing services to public sector agencies and clients in the health and human services area. Ms. Laub has 29 years of experience in the healthcare industry. Previously, she was CEO-in-Residence of MML Group of Scottsdale, Ariz., which provided consulting services for private equity firms. Prior to that, she was president and founder of McKesson Healthcare Delivery Systems; she also held the position of president of McKesson Health Solutions. Ms. Laub holds a B.S. in Food Science from North Dakota State University at Fargo, and completed graduate-level studies in accounting at Northern Illinois University at DeKalb.

"The addition of Margaret adds a great industry-specific dimension we will use as we continue to build our business," Klopack said.

Two current board members, Mr. Peter Craddock, Managing Director, Shoreline Venture Management and Mr. Gerry Forth, co-founder of IntelliDOT, are stepping down from the board after providing more than six years of service and guidance. Both will continue to be involved with IntelliDOT's success as observers.

"As two of our original board members, Peter and Gerry were very helpful as they assisted in guiding us from the start-up phase to achieving a number of important development and financing milestones. We look forward to continuing to draw on their financial and industry experience in their observer roles as the company continues to grow," said Klopack.

The new IntelliDOT Board of Directors is comprised of the following individuals:

  • Dick Allen, President, DIMA Ventures
  • Douglas C. Carlisle, Managing Director, Menlo Ventures
  • Dr. Mike Guthrie, Executive-in-Residence, University of Colorado-Denver School of Business
  • Thomas G. Klopack, President and CEO of IntelliDOT Corporation
  • John Kunhart, Managing Director and co-founder, American River Ventures
  • Margaret Laub, Chief Executive Officer, Policy Studies Inc
  • Lisa Suennen, Managing Member and co-founder, Psilos Group

The IntelliDOT System is a best-of-breed wireless, workflow manager that connects caregivers with the information systems they need at the point-of-care. Designed by nurses for nurses, the IntelliDOT System enables clinicians to perform safety checks and safely administer and document medications at the bedside using a lightweight, handheld device. The IntelliDOT System satisfies Joint Commission standards for patient identification and assures accuracy by verifying the five rights of medication administration: right medication, right dose, right route, right patient, right time; as well as ensuring required follow-up documentation, such as pain scale, is performed in a timely manner and accurately recorded.

About IntelliDOT(R) Corporation

IntelliDOT is a leading provider of wireless, handheld, barcode point-of-care (BPOC) solutions that connect to any healthcare information system to improve patient safety and nurse workflow. When using IntelliDOT Bedside Medication Administration, nurses can easily manage all tasks associated with five rights medication administration safety checks and related documentation. Additional system modules that run on the same handheld device include: IntelliDOT Phlebotomy Specimen Collection(TM), IntelliDOT Blood Product Administration(TM), IntelliDOT Mother-Baby Breast Milk Matching(TM), and IntelliDOT Vital Signs Collection(TM). More information can be found at www.intellidotcorp.com.

Except for the historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties, including, but not limited to, risks and uncertainties associated with market acceptance of the CAREt System, whether the company will be successful in raising additional funds, the risk that sales of the CAREt System will not increase to target levels, and the effectiveness and marketability of healthcare information technologies, as well as other risks.

IntelliDOT is a registered trademark of IntelliDOT Corporation. Other product and company names in this news release are trademarks and/or registered trademarks of their respective companies.

    Media & Analyst Contact:
    Michael E. Donner
    VP Marketing and Inside Sales
    IntelliDOT Corporation
    +1 (858) 746-3104
    mdonner@intellidotcorp.com


'/>"/>
SOURCE IntelliDOT Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Margaret Dimond Named President and CEO of McLaren Medical Management Inc.
2. ABMS Appoints Margaret Jung As New COO
3. Dr. Allen Woolf Appointed Chief Medical Officer For CIGNA Group Insurance
4. William Moore Appointed to IRIDEX Board of Directors
5. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
6. Katie Hood Appointed Interim Chief Executive Officer of Michael J. Fox Foundation
7. James B. Hawkins Appointed to IRIDEX Board of Directors
8. Bryan R. Rogers Appointed President of Far West Division
9. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
10. Catholic Health Association Disappointed by Failure to Override SCHIP Veto
11. Steven M. Safyer, MD, Appointed President and CEO of Montefiore Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... ... With over 60 percent of acute stroke survivors being left unable to ... in the rehabilitation process has steadily increased. Ekso Bionics had been working to help ... stroke. , Ekso Bionics has now received clearance from the U.S. Food and Drug ...
(Date:5/27/2016)... ... 27, 2016 , ... In response to meager public awareness, ... of the plight of aphasia. In collaboration with the American Aphasia Association, a ... The link between stroke and aphasia is relatively unknown, but through collaboration with ...
(Date:5/27/2016)... , ... May 27, 2016 , ... Aimed at nurses ... interest stories, which come courtesy of leaders in the nursing and health care industry. ... leading advocates and associations—namely Abilene Christian University. , As the nursing industry is ...
(Date:5/26/2016)... ... ... Despite last week’s media reports hinting at a June rate hike after the Federal ... an interest rate increase, according to Rajeev Dhawan of the Economic Forecasting Center at ... Committee (FOMC) dot charts are of interest to the press for their noise potential,” ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cabot Corporation, ... defective respirators, according to court documents and SEC filings. A jury has ... Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles County, California. The ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... May 27, 2016 Amarantus BioScience Holdings, ... developing products for Regenerative Medicine, Neurology and Orphan Diseases, today announced ... presenting at two upcoming investor conferences: SeeThru Equity ... Avenue, New York City , NY ... Marcum MicroCap Conference   Where: Grand Hyatt Hotel, ...
(Date:5/26/2016)... , May 26, 2016   ... software and analytics, network solutions and technology-enabled ... announced it entered into a strategic channel ... of outpatient software solutions and revenue cycle ... specialty hospitals and rehabilitation clinics to optimize ...
(Date:5/25/2016)... and GERMANTOWN, Maryland , May ... QGEN ; Frankfurt Prime Standard: QIA) today announced that ... with Therawis Diagnostics GmbH to develop and commercialize predictive assays ... market PITX2 as a marker to predict effectiveness of anthracycline ... "We are pleased to partner with Therawis, which ...
Breaking Medicine Technology: